Caas Capital Management LP Adaptive Biotechnologies Corp Transaction History
Caas Capital Management LP
- $1.31 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
201Shares Held
146MCall Options Held
2.6KPut Options Held
143K-
Viking Global Investors LP30MShares$106 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$45.6 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$41 Million0.35% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$39.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.6MShares$37.4 Million0.24% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $506M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...